Kerri Smith

Dr. Kerri Smith


Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2012 in Journal of Biological Chemistry
Verified
Journal Article
Open access
PLPeter S. Levitt
Peter S. Levitt
Krisztina M. Papp-WallaceKrisztina M. Papp-Wallace
Krisztina M. Papp-Wallace
MTMagdalena A. Taracila
Magdalena A. Taracila
AHAndrea M. Hujer
Andrea M. Hujer
MWMarisa L. Winkler
Marisa L. Winkler
Robert BonomoRobert Bonomo
Robert Bonomo
Gram-negative bacteria harboring KPC-2, a class A β-lactamase, are resistant to all β-lactam antibiotics and pose a major public health threat. Arg-164 is a conserved residue in all class A β-lactamases and is located in the solvent-exposed Ω-loop of KPC-2. To probe the role of this amino acid in KPC-2, we performed site-saturation mutagenesis. When compared with wild type, 11 of 19 variants at position Arg-164 in KPC-2 conferred increased resistance to the oxyimino-cephalosporin, ceftazidime (minimum inhibitory concentration; 32→128 mg/liter) when expressed in Escherichia coli. Using the R164S variant of KPC-2 as a representative β-lactamase for more detailed analysis, we observed only a modest 25% increase in k(cat)/K(m) for ceftazidime (0.015→0.019 μm(-1) s(-1)). Employing pre-steady-state kinetics and mass spectrometry, we determined that acylation is rate-limiting for ceftazidime hydrolysis by KPC-2, whereas deacylation is rate-limiting in the R164S variant, leading to accumulation of acyl-enzyme at steady-state. CD spectroscopy revealed that a conformational change occurred in the turnover of ceftazidime by KPC-2, but not the R164S variant, providing evidence for a different form of the enzyme at steady state. Molecular models constructed to explain these findings suggest that ceftazidime adopts a unique conformation, despite preservation of Ω-loop structure. We propose that the R164S substitution in KPC-2 enhances ceftazidime resistance by proceeding through "covalent trapping" of the substrate by a deacylation impaired enzyme with a lower K(m). Future antibiotic design must consider the distinctive behavior of the Ω-loop of KPC-2.

1 December 2013 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
SKSebastian G. Kurz
Sebastian G. Kurz
KWKerstin A. Wolff
Kerstin A. Wolff
SHSaugata Hazra
Saugata Hazra
CBChristopher R. Bethel
Christopher R. Bethel
AHAndrea M. Hujer
Andrea M. Hujer
Robert BonomoRobert Bonomo
Robert Bonomo
The current emergence of multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis calls for novel treatment strategies. Recently, BlaC, the principal β-lactamase ofMycobacterium tuberculosis, was recognized as a potential therapeutic target. The combination of meropenem and clavulanic acid, which inhibits BlaC, was found to be effective against even extensively drug-resistantM. tuberculosisstrains when testedin vitro. Yet there is significant concern that drug resistance against this combination will also emerge. To investigate the potential of BlaC to evolve variants resistant to clavulanic acid, we introduced substitutions at important amino acid residues ofM. tuberculosisBlaC (R220, A244, S130, and T237). Whereas the substitutions clearly led toin vitroclavulanic acid resistance in enzymatic assays but at the expense of catalytic activity, transformation of variant BlaCs into anM. tuberculosisH37Rv background revealed that impaired inhibition of BlaC did not affect inhibition of growth in the presence of ampicillin and clavulanate. From these data we propose that resistance to β-lactam–β-lactamase inhibitor combinations will likely not arise from structural alteration of BlaC, therefore establishing confidence that this therapeutic modality can be part of a successful treatment regimen againstM. tuberculosis.

1 August 2012 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Closed access
PDF file
Krisztina M. Papp-WallaceKrisztina M. Papp-Wallace
Krisztina M. Papp-Wallace
MTMagdalena A. Taracila
Magdalena A. Taracila
KSKerri Smith
Kerri Smith
YXYan Xu
Yan Xu
Robert BonomoRobert Bonomo
Robert Bonomo
β-Lactamases are important antibiotic resistance determinants expressed by bacteria. By studying the mechanistic properties of β-lactamases, we can identify opportunities to circumvent resistance through the design of novel inhibitors. Comparative amino acid sequence analysis of class A β-lactamases reveals that many enzymes possess a localized positively charged residue (e.g., R220, R244, or R276) that is critical for interactions with β-lactams and β-lactamase inhibitors. To better understand the contribution of these residues to the catalytic process, we explored the roles of R220 and E276 in KPC-2, a class A β-lactamase that inactivates carbapenems and β-lactamase inhibitors. Our study reveals that substitutions at R220 of KPC-2 selectively impact catalytic activity toward substrates (50% or greater reduction in k cat / K m ). In addition, we find that residue 220 is central to the mechanism of β-lactamase inhibition/inactivation. Among the variants tested at Ambler position 220, the R220K enzyme is relatively “inhibitor susceptible” ( K i of 14 ± 1 μM for clavulanic acid versus K i of 25 ± 2 μM for KPC-2). Specifically, the R220K enzyme is impaired in its ability to hydrolyze clavulanic acid compared to KPC-2. In contrast, the R220M substitution enzyme demonstrates increased K m values for β-lactamase inhibitors (>100 μM for clavulanic acid versus 25 ± 3 μM for the wild type [WT]), which results in inhibitor resistance. Unlike other class A β-lactamases (i.e., SHV-1 and TEM-1), the amino acid present at residue 276 plays a structural rather than kinetic role with substrates or inhibitors. To rationalize these findings, we constructed molecular models of clavulanic acid docked into the active sites of KPC-2 and the “relatively” clavulanic acid-susceptible R220K variant. These models suggest that a major 3.5-Å shift occurs of residue E276 in the R220K variant toward the active S70 site. We anticipate that this shift alters the shape of the active site and the positions of two key water molecules. Modeling also suggests that residue 276 may assist with the positioning of the substrate and inhibitor in the active site. These biochemical and molecular modeling insights bring us one step closer to understanding important structure-activity relationships that define the catalytic and inhibitor-resistant profile of KPC-2 and can assist the design of novel compounds.

Verified
Journal Article
Open access
PDF file
YWYan-Hong Wang
Yan-Hong Wang
YMYonghai Meng
Yonghai Meng
CZChunmei Zhai
Chunmei Zhai
MWMei Wang
Mei Wang
BABharathi Avula
Bharathi Avula
IKIkhlas Khan
Ikhlas Khan
Eleutherococcus senticosus Maxim. belongs to the Araliaceae family. Phytochemical studies reveal that E. senticosus leaves contain triterpene glycosides along with organic acid derivatives and flavonoid compounds. It is believed that E. senticosus is similar to ginseng because they come from same family and both contain triterpene saponins. E. senticosus leaves have been developed as a functional beverage called ci-wu-jia tea in recent years. Triterpene glycosides are difficult to identify by ultraviolet (UV) detection and contents of these compounds are low in E. senticosus leaves. In this study, a sensitive ultra-high performance liquid chromatographic (UHPLC) method combining UV and tandem mass spectrometry (MS/MS) was developed to characterize the triterpene glycosides from E. senticosus leaves and related commercial products. Fragmentation patterns of three sub-groups of triterpene glycosides in E. senticosus leaves were investigated. Additionally, fragmentation pathways and UV characteristics of organic acid derivatives and flavonoids were also characterized. A compound screening library, including 241 compounds reported in the literature, was created and used to confirm the compounds in the samples. In this study, a total of 24 samples, including 13 plant samples of E. senticosus and 11 ci-wu-jia tea products, were analyzed. Out of the 11 commercial products, three products were discovered to contain green tea (Camellia sinensis) that was considered to be an adulterant since it was not an ingredient on the labels. The developed UHPLC-UV-MS/MS analytical method combined with the UNIFI processing method can simultaneously characterize organic acid derivatives, flavonoids, and triterpene saponins from E. senticosus. It provides a simple and sensitive way to perform quality control of E. senticosus and related ci-wu-jia tea products.

28 March 2012 in Bioanalysis
Verified
Journal Article
Closed access
KSKerri Smith
Kerri Smith
YXYan Xu
Yan Xu
Analytical quantitation of compounds in tissue has become a more prevalent addition to biological sample analysis in recent times. This increase will most certainly continue to bring the question of proper analytical method validation to the forefront of discussion. Thoughtful design of sample homogenization, analyte fortification and extraction can ensure a successful analysis. This review presents current trends in tissue sample preparation by harvesting, homogenization techniques, as well as concerns for calibrator and QC preparation. Strategies for consideration and resolution of common pitfalls in method development, for example stability issues and control biomatrices in endogenous analysis, are also presented.

19 December 2012 in Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
MWMarisa L. Winkler
Marisa L. Winkler
ERElizabeth A. Rodkey
Elizabeth A. Rodkey
MTMagdalena A. Taracila
Magdalena A. Taracila
SDSarah M. Drawz
Sarah M. Drawz
CBChristopher R. Bethel
Christopher R. Bethel
Robert BonomoRobert Bonomo
Robert Bonomo